Batch 001 - Live Allocation
Next Release: Aug 2026
Demo · Switch Role
Demo mode. In production, this would be authentication-driven. Each role sees only what's relevant to their workflow.
VL
Vivre Labs
Institutional Longevity
- Peptides -
- Single-vial Blends -
- Goals -
- Clinical Reference -
- Guides -
- Integrity -

◇ Compound Reference

GROWTH HORMONE SUPPORT

Tesamorelin

GHRH Analog · 20mg

Vial size
MechanismGHRH Receptor Agonism
Educational reference only - not a prescription or dosing recommendation. Some compounds are investigational or used off-label; suitability, dose, and monitoring are determined by your supervising physician. See Informed Consent & Disclaimer.
V-Series Member
$160 USD/vial
À-la-carte: $180 USD/vial · Save 11%
Vials per allocation
Member total (1×)$160
À-la-carte total$180
Flat per-vial pricing. Quantity is allocated and dispensed within your physician-supervised protocol - not a direct sale.
What this is

Larger 20mg vial of Tesamorelin - the most cost-efficient size for sustained 2mg/day dosing (3 vials ≈ one month). Best per-mg value of the three vial sizes.

GHRH Analog · 20mg per vial · dispensed after a physician review.

◇
Janoshik Verified
HPLC + MS purity, every batch
Independent third-party lab
⬡
COA Per Batch
Lot-level certificates published
Labeled vs actual mg disclosed
⊙
Protocol Reviewed
Used in V-Series clinical stacks
Phase 1 supervision onboarding
Used inV-Series
V-03
Metabolic - Weight & Blood Sugar
Popular · GLP-1 + Lean Mass
V-G1
Build - Lean Mass & Sleep Quality
Popular · GH-Axis Recovery
Tesamorelin · Growth hormone support
◆ Certificate of Analysis · Tesamorelin
JANOSHIK ANALYTICALHPLC + MS · Independent third-party
Batch 001 · lot VL-TES-2026-07A

Every 100 units are drawn from one lot and tested once. The certificate below is the one that applies to this batch - when it closes, the next opens with a new lot and a new certificate.

Lot · Tesamorelin-2026-07-30
97.423%
Labeled
5 mg
Actual (HPLC)
4.73 mg
Method
HPLC + MS
Tested
Jul 30, 2026
Endotoxin
not tested for this lot
Heavy metals
not tested for this lot
Janoshik AnalyticalPURITY PDF →
Verify independently at janoshik.com/verificationPurity - code 9PCF8V7IKJBR
✚
Patient Bloodwork Guide
Bloodwork for Growth-Hormone Protocols

GHRH / GHRP secretagogues - Tesamorelin, CJC-1295, Ipamorelin, V-G1

These protocols gently restore your body’s own pulsing release of growth hormone rather than replacing it. Because growth hormone also affects blood sugar, monitoring confirms two things: that it is working, and that it is doing so safely.

Incremental approach. Vivre starts below the standard dose and advances only on tolerance. This monitoring is the safety scaffold for that conservative approach.

Is it working? (Efficacy)
IGF-1The main signal of your overall growth-hormone output across the day.
IGFBP-3The protein that carries IGF-1 - measured alongside it for a clearer picture of how much is active.
Blood sugar & metabolism (watch closely)
Fasting insulinThe earliest warning sign of insulin resistance - it moves before blood sugar does.
HbA1cYour average blood sugar over ~3 months. Especially relevant with Tesamorelin.
Fasting glucoseA routine blood-sugar check.
Keeping side effects in check
ProlactinIpamorelin (the one Vivre uses) is highly selective and rarely affects this; checked as good practice.
Cortisol (AM)A stress-hormone check included for completeness.
Overall safety
hs-CRPA sensitive inflammation marker - confirms recovery, not strain.
CBC & CMPStandard blood count, liver, and kidney panels.
When the tests happen
Baseline (before you start)Full panel - your natural starting point.
Mid-cycle (week 6–8)IGF-1, fasting insulin, prolactin/cortisol - confirm it works, catch sugar drift early.
Post-cycle (4 weeks off)IGF-1 and fasting insulin - confirm natural production recovers.

Educational only - not medical advice or a dosing instruction. Your physician orders the tests, sets your dose, interprets results, and decides if a protocol is right for you. See the Informed Consent & Disclaimer for full terms.

▣
Featured In
V-Series Protocols Including Tesamorelin
V-03
Metabolic - Weight & Blood Sugar
Visceral fat reduction with lean mass and dermal preservation
Contains
Tirzepatide (Base Form)Tesamorelin
V-G1
Build - Lean Mass & Sleep Quality
Natural GH-pathway optimization, without exogenous GH risks
Contains
CJC-1295 (No DAC)Ipamorelin
READY TO PROCEED

Start with the Biological Audit

Tesamorelin is verified and lot-tested, dispensed following a Biological Audit. The Audit is complimentary for the Batch 001 cohort.

$160 USD/vial
Tesamorelin · Member rate
VL
Vivre Labs
Institutional Longevity

Clinical optimization through institutional medicine. All protocols verified and lot-tested, MSO-administered, hospital-integrated.

V-Series

Peptides

Metabolic
Repair & Aesthetic
Neurological
Growth & Hormonal
Longevity & Immune
Sexual Health

Navigate

Verification

Legal

DEMO SITE - PRESENTATION PURPOSES ONLY. All protocols verified and lot-tested, dispensed after comprehensive medical evaluation. Compounds sourced from registered cGMP compounding pharmacies. Individual results vary. MSO structures and revenue models are illustrative for partner conversations. Regulatory outcomes reference publicly disclosed FDA processes and are anticipated but not guaranteed.

© 2026 Vivre Labs. All rights reserved.

cGMPLot-TestedDemo

Demonstration prototype - not a live service